Human Reproduction, Vol. 14, No. 4, 1028-1033,
April 1999
© 1999 European Society of Human Reproduction and Embryology
Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study
Institute of Reproductive Medicine of the University, Domagkstr. 11, D-48129 Münster, Germany
In a randomized, placebo-controlled, double-blind study we investigated whether high-dose oral treatment with vitamins C and E for 56 days was able to improve semen parameters of infertile men. Ejaculate parameters included semen volume, sperm concentration and motility, and sperm count and viability. Thirty-one patients without genital infection but with asthenozoospermia (<50% motile spermatozoa) and normal or only moderately reduced sperm concentration (>7x106 spermatozoa/ml) (according to WHO criteria) were examined. To investigate the influence of the epididymal storage period on semen parameters, the patients were asked to deliver two semen samples with abstinence times of 2 and 7 days both before and at the end of vitamin treatment. After randomization, the patients received either 1000 mg vitamin C and 800 mg vitamin E (n = 15) or identical placebo capsules (n = 16). No changes in semen parameters were observed during treatment, and no pregnancies were initiated during the treatment period. Combined high-dose antioxidative treatment with vitamins C and E did not improve conventional semen parameters or the 24-h sperm survival rate. Prolonged abstinence time increased ejaculate volume (P < 0.05), sperm count (P < 0.05), sperm concentration (P < 0.05) and the total number of motile spermatozoa (P < 0.05).
Key words: alpha-tocopherol/ascorbic acid/asthenozoospermia/male infertility/vitamins
1 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Vujkovic, J.H. de Vries, G.R. Dohle, G.J. Bonsel, J. Lindemans, N.S. Macklon, P.J. van der Spek, E.A.P. Steegers, and R.P.M. Steegers-Theunissen Associations between dietary patterns and semen quality in men undergoing IVF/ICSI treatment Hum. Reprod., June 1, 2009; 24(6): 1304 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tremellen Oxidative stress and male infertility--a clinical perspective Hum. Reprod. Update, May 1, 2008; 14(3): 243 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. M. Lewis and I. M. Agbaje Using the alkaline comet assay in prognostic tests for male infertility and assisted reproductive technology outcomes Mutagenesis, May 1, 2008; 23(3): 163 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.M.W. Ebisch, C.M.G. Thomas, W.H.M. Peters, D.D.M. Braat, and R.P.M. Steegers-Theunissen The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility Hum. Reprod. Update, March 1, 2007; 13(2): 163 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wang, G. Wang, B. E. Barton, T. F. Murphy, and H. F. S. Huang Beneficial Effects of Vitamin E in Sperm Functions in the Rat After Spinal Cord Injury J Androl, March 1, 2007; 28(2): 334 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Agarwal, S. A. Prabakaran, and T. M. Said Prevention of Oxidative Stress Injury to Sperm J Androl, November 1, 2005; 26(6): 654 - 660. [Full Text] [PDF]
|
|
|
|
|
|
G. Cavallini Response: Responsiveness to Tamoxifen Citrate and Testosterone Undecanoate Is Independent of the Severity of Idiopathic Oligozoospermia J Androl, September 1, 2005; 26(5): 566 - 567. [Full Text] [PDF]
|
|
|
|
|
|
E. Greco, M. Iacobelli, L. Rienzi, F. Ubaldi, S. Ferrero, and J. Tesarik Reduction of the Incidence of Sperm DNA Fragmentation by Oral Antioxidant Treatment J Androl, May 1, 2005; 26(3): 349 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Eskenazi, S.A. Kidd, A.R. Marks, E. Sloter, G. Block, and A.J. Wyrobek Antioxidant intake is associated with semen quality in healthy men Hum. Reprod., April 1, 2005; 20(4): 1006 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cavallini, A. P. Ferraretti, L. Gianaroli, G. Biagiotti, and G. Vitali Cinnoxicam and L-Carnitine/Acetyl-L-Carnitine Treatment for Idiopathic and Varicocele-Associated Oligoasthenospermia J Androl, September 1, 2004; 25(5): 761 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Sikka Role of Oxidative Stress and Antioxidants in Andrology and Assisted Reproductive Technology J Androl, January 1, 2004; 25(1): 5 - 18. [Full Text] [PDF]
|
|
|
|
|
|
J. G. Alvarez Nurture vs Nature: How Can We Optimize Sperm Quality? J Androl, September 1, 2003; 24(5): 640 - 648. [Full Text] [PDF]
|
|
|
|
|
|
F. Comhaire Clinical andrology: from evidence-base to ethics: The `E' quintet in clinical andrology Hum. Reprod., October 1, 2000; 15(10): 2067 - 2071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M.A. Mahmoud, F. H. Comhaire, A. B. Christophe, C. Rolf, T.G. Cooper, and E. Nieschlag Oral antioxidants and male infertility Hum. Reprod., December 1, 1999; 14(12): 3149 - 3150. [Full Text] [PDF]
|
|